CSL Behring Announces Closing of Global Commercialization and License Agreement with uniQure for etranacogene dezaparvovec

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. USO
7. APGE
8. ABBV
9. DFTX
10. MSFT

Go back to CSL Behring Announces Closing of Global Commercialization and License Agreement with uniQure for etranacogene dezaparvovec
CARLISLE COMPANIES, Inc. (NYSE: CSL) Delayed: 360.96 --0 (-0%)
Previous Close $360.96    52 Week High $114.49 
Open $360.96    52 Week Low $75.17 
Day High $360.96    P/E 99.99 
Day Low $360.96    EPS $3.61 
Volume 1       

(AMEX: CSLLY) Delayed: 19.88 --0 (-0%)
Previous Close $19.88    52 Week High $45.60 
Open $19.88    52 Week Low $33.39 
Day High $19.88    P/E N/A 
Day Low $19.88    EPS $0.00 
Volume 21       

UNIQURE (NASDAQ: QURE) Delayed: 44.39 --0 (-0%)
Previous Close $44.39    52 Week High $22.79 
Open $44.39    52 Week Low $6.63 
Day High $44.39    P/E N/A 
Day Low $44.39    EPS $0.00 
Volume 9,980